Metagenomi Therapeutics MGX
NASDAQ MGX
$1.02 -0.09 (-8.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Metagenomi Therapeutics (MGX) Asset Writedowns and Impairment (2023 - 2025)

Updated

Metagenomi Therapeutics' Asset Writedowns and Impairment was $181,000 in Q3 2025, compared with $11,000 a year earlier.

Analysis

Metagenomi Therapeutics (MGX) Asset Writedowns and Impairment (2023 - 2025) Analysis & Trends

On a trailing twelve-month basis, Metagenomi Therapeutics' Asset Writedowns and Impairment was $933,000 through Sep 30, 2025, up 206.9% year-over-year; for FY2024, it came in at $1.04 million.

  • In earlier years, Asset Writedowns and Impairment was $23,000 in FY2023.
  • Quarterly Asset Writedowns and Impairment has moved between $4,000 (Q1 2024) and $752,000 (Q4 2024) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Metagenomi Therapeutics 38.53 Mn 38.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 181,000.00
Dec 31, 2024 752,000.00
Sep 30, 2024 11,000.00
Jun 30, 2024 275,000.00
Mar 31, 2024 4,000.00
Dec 31, 2023 14,000.00
API Access

Metagenomi Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=MGX&period=max&api_key=YOUR_API_KEY